Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NCT: NCT07521475 · NOT_YET_RECRUITING
Brief Summary
A multi-center, 26-week randomized controlled trial (RCT) to evaluate the safety and efficacy of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, with the primary endpoint after 15 weeks and secondary analysis at 26 weeks; followed by an extension phase after completion of the 26-week trial where the Intervention group will continue to use Omnipod M and the Control group will crossover to use Omnipod M for 26 weeks
Frequently Asked Questions
What is Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes?
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes is a clinical trial registered under NCT07521475. Current status: NOT_YET_RECRUITING.
What is the status of NCT07521475?
The current status of NCT07521475 (Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes) is: NOT_YET_RECRUITING.
When did Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes start?
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes started on 2026-04-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.